In June, a key presentation will unfold outlining the latest report on multiple sclerosis, organized by Prensa Ibérica and supported by Novartis. The event aims to spotlight shifts in planning and management of MS in Spain, with the clear goal of improving health outcomes for those living with the disease. The session promises to illuminate new approaches and practical insights that can influence policy, clinical practice, and patient care across the country.
Leading the talk will be Pedro Carrascal, Executive Director of Multiple Sclerosis Spain (EME Spain). His address will set the stage for a broader dialogue among top experts in the field. Attendees can expect a synthesis of current research, clinical experience, and patient-centered considerations designed to drive meaningful improvements in MS care.
The event will feature a scholarly colloquium featuring renowned specialists. Among the participants are Miguel Angel Llaneza, Head of the Neurological Service at the Central University Hospital of Asturias and coordinator of the Spanish Neurological Society Demyelinating Diseases Working Group; Beatrice del Rio, Coordinator of the Multiple Sclerosis Working Group of the Spanish Neurological Nursing Society (SEDENE); Peter Carrascal, Managing Director of Multiple Sclerosis Spain (EME Spain); a senior hospital leader identified as the Director of the Hospital Universitario del Sureste de Madrid (SERMAS); and Paula Gomez – Angulo Amoros, Director General of Humanization and Patient Care for the Community of Madrid. The assembled experts will explore important questions about management, accessibility, and the patient experience in MS care, grounding the discussion in real-world data and clinical practice across Spain.
The venue for the presentation is Espacio Bertelsmann in Madrid, with arrangements in place to stream the content for readers associated with the editorial group. The event responds to a growing demand for transparent, evidence-based information on MS and aims to reach a broad audience, including healthcare professionals, policymakers, and those affected by the condition and their families.
event schedule
The program begins at 4:30 in the afternoon with an opening welcome by Jesús Javier Prado, the editor responsible for El Periódico de España. A keynote intervention from Novartis follows at 16:32, presenting perspectives on the role of current therapies and emerging options in the management of MS. At 16:37, Pedro Carrascal will present the core findings of the report titled “Point About MS,” highlighting how the new insights can shape care planning and resource allocation in Spain. The session then moves into a moderated colloquium at 16:45, featuring a panel of experts who will discuss implementation challenges, patient access, and strategies to improve outcomes. The event is scheduled to conclude at 18:00, leaving room for further dialogue and networking among attendees.
Throughout the afternoon, participants will have opportunities to engage with the material, ask questions, and consider how the evidence presented may inform local decision-making and clinical protocols. The organization emphasizes practical relevance, aiming to translate research into actions that benefit patients and the broader MS community across Spain and beyond.
“The Point About MS” — a focused exploration of the report’s implications for care, policy, and patient experience — will be highlighted as a guiding thread, underscoring the collaboration between researchers, clinicians, patient advocates, and healthcare leaders. Attendees are encouraged to take away actionable insights that can be applied within their own settings and contribute to ongoing improvements in MS management. The event’s inclusive format and streaming options ensure wide accessibility for readers and stakeholders who cannot attend in person.